Facebook link Linked In link You Tube link

FOCIS 2015 Banner

Register Now!

Register now for FOCIS 2015, the premier meeting in translational immunology! The meeting includes more than 15 scientific sessions including top clinicians and researchers from around the globe, speaking on cutting-edge topics across immunology and its related fields. Become a FOCIS member prior to registering to secure the lowest registration rates!

Preliminary Program: 
Check out the Preliminary Program to see all that FOCIS 2015 has to offer! Don't miss the keynote presentations by Ron Germain, MD; PhD, Anjana Rao, PhD; and Jeffrey Bluestone, PhD.

FOCIS 2015 Hotel

Meeting Location:
Hilton San Diego Bayfront
One Park Blvd.
San Diego, California

Book your room at the FOCIS rate of $235/night for regular attendees and $199/night for trainees.

FOCIS Educational Courses

FOCIS is excited to offer four educational courses prior to FOCIS 2015! Click here to learn more about each course and take advantage of the package rates with your conference registration!

rsz logo basic

Basic Immunology in Medicine: June 23, 8:00am – 5:00pm

  • Describe major advances in basic immunology that are most relevant to human diseases
  • Identify the basic principles underlying therapeutic modulation of the immune system
rsz logo computational

*NEW* Computational Immunology: June 23, 8:00am – 5:00pm

  • Discuss the basic principles, challenges and applications of bioinformatics data analysis
  • Describe scientific reports on analysis of multidimensional data (NGS, microarray, mass/flow cytometry)
rsz logo interventional

Interventional Immunology: June 24, 8:00am – 12:00pm

  • Identify the scientific basis for choice of immunologically related therapeutic targets in various diseases
  • Analyze how a physician should decide to use and choose therapies
rsz logo clinicaltrials

Clinical Trials for Immunologic Disease: June 24, 1:00pm – 5:00pm

  • Review the key elements of clinical trials, including statistical issues and surrogate markers
  • Discuss strategies for entering into the funding system

New Computational Immunology Course in the FOCISed Lineup at FOCIS 2015!

email logo computational

FOCIS is excited to announce Computational Immunology, a new course, to be offered June 23 in San Diego prior to FOCIS 2015! This new course is aimed at scientists involved or interested in the use of multi-dimensional data generated by modern genomics and proteomics technologies such as mass/flow cytometry, next-generation sequencing and microarrays. The course will also provide a better basic understanding of modern statistical and mathematical concepts necessary for their analysis and interpretation.

The course will be led by bioinformatics experts Dr. Magnus Fontes from Lund University in Sweden and Dr. Emanuele de Rinaldis of King's College London. This exciting new course will feature a half day of presentations along with case studies and an interactive review session. Scientific case studies will be presented with results, conclusions and suggestions discussed. Attendees will form teams to review a pre-selected scientific paper and present their analysis and answers in a moderated discussion.

Along with Computational Immunology, FOCIS will provide 3 additional educational courses prior to the FOCIS 2015 meeting. These courses provide attendees with an opportunity to advance their careers by learning from world-renowned faculty members. All of the courses will be held at the Hilton San Diego Bayfront, the FOCIS 2015 headquarters, on June 23-24. Package rates are available along with discounted prices for trainees and fellows. Click here to learn more and register today! 

FOCIS Loves Our Member Societies!

Each year the FOCIS Member Societies shine as they bring the most recent developments from their fields to the FOCIS meeting. Don't forget to arrive early to attend these sessions on June 24 as they kick off FOCIS 2015! 

The FOCIS Commmunities of Practice is the areas of cancer and immunology will also be presenting exciting sessions on that day.

rsz member socety symposia

The Latest in Translational Immunology News in One Publication!

rsz epub

The newest installation of the members-only publication, Translational Immunology Update is now available. The titles from each publication are available for viewing on the FOCIS homepage. To view a free issue, click here. The link will expire after 60 days.

Titles from the issue include:

  • Modulation of CD4+ T Cell Metabolism Improves Lupus
    Reviewed by Rachel Clark, MD, PhD, Brigham and Women's Hospital
  • Nature or Nuture in T Cell Differentiation?
    Reviewed by Sarah Henrickson, MD, PhD, Children's Hospital of Philadelphia
  • Plasmablasts Induce Tfh Differentiation via IL-6 Production
    Reviewed by Michelle L. Hermiston, MD, PhD, University of California, San Francisco
  • IL-9 in Peanut Allergy
    Reviewed by Kari Nadeau, MD, PhD, Stanford University
  • Read More . . .

Lupus Insight Prize

newsletter lupus photo

FOCIS 2015 will once again host the forum for the Lupus Foundation of America, Alliance for Lupus Research and Lupus Research Institute to award the Lupus Insight Prize. The Lupus Insight Prize recipient will be awarded $200,000 to be used for research dedicated to advancing understanding of the genetic, environmental, molecular, immunologic or cellular aspects of lupus and/or its treatment. The prize must be utilized within three years from the date awarded.

LRI Scientific Advisory Board Member and Editor-in-Chief of Arthritis Research and Therapy Peter Lipsky, MD noted, "Lupus is a complex disease that requires out-of-the-box thinking to increase understanding and further our ability to treat persons with this disease effectively. Quantum leaps in understanding lupus will come from innovative discoveries by outstanding scientists. The Lupus Insight Prize will recognize those novel discoveries."

The 2015 Prize will be awarded by the three organizations on Wednesday, June 24 at FOCIS 2015, in San Diego, California.

2015: Advanced Course Recap

The 2015 Advanced Course in Basic & Clinical Immunology was held in early February to rave reviews. Over 80 attendees from around the globe joined the world-renowned faculty in Scottsdale for three days of intensive learning and networking. As the most popular FOCIS educational course, the Advanced Course is always a big hit so make sure to mark your calendars for February 4-6, 2016!

2015: Advanced Course

Unique Features

  • Great value compared to other courses
    • Registration includes hotel and meals
  • Located at a beautiful resort in sunny Scottsdale, Arizona
  • Significant networking time with faculty

Immunology Education on the Go

Can't make it to San Diego? Access educational programming on demand! FOCIS members receive free access - Join today! CME is avaliable! The following courses are available through the FOCISed Online CME Portal:

  • Advanced Course in Basic & Clinical Immunology
  • Basic Immunology in Medicine
  • Interventional Immunology
  • Clinical Trials for Immunologic Disease

Watch a sneak peak of Abul Abbas, MD at the Basic Immunology course!

Entrepreneurs in Clinical AcademiaEntrepreneurs in Clinical Academia (ECA) Course

The Entrepreneurs in Clinical Academia (ECA) course is returning in 2015! Following on from two successful years, the course has been as popular as ever. The calibre of candidates has been high, with scientists applying from over 13 countries. There are only 20 places available, and so the adjudication panel now has the difficult task of selecting the successful delegates for this exciting course.

From the drug development process, to understanding intellectual property law, the 5-day ECA course provides key insights to help clinical researchers and academics turn an innovation into a marketable success. Find out more information about the course by watching the new video, which can be found HERE.

Anthony WilliamsThe ECA course has had outstanding feedback from past delegates:

  • "ECA 2014 was open, fresh and interactive. It's rare to meet, within the same week, a patent lawyer, a venture capitalist, an expert in tech transfer. It's a very unique opportunity." - Anthony Williams, University of Southampton, UK

The initiative, led by the Federation of Clinical Immunology Societies (FOCIS) and supported by Celgene, is designed to foster mutual understanding and co-operation between public research and the private sector. Delivered by the globally renowned business school Institut Européen d'Administration des Affaires (INSEAD) situated in the outskirts of Paris, the course provides clinical researchers with key insights to take their innovative research out of the laboratory and onto the pharmaceutical market place.

This course will be held at INSEAD, Fontainebleau; September 21–25, 2015. The ECA course is a meeting supported by Celgene. Celgene (www.celgene.com) is delighted to partner with FOCIS and INSEAD in this project, and is closely aligned with the FOCIS goals of fostering interdisciplinary approaches to improve translation of scientific ideas and observations into therapeutics and benefits for patients in Immune and Inflammatory diseases.

Immunology Catalyst

You're invited to apply for the Elion and Black Immunology Catalyst Sabbatical Program at GSK!

email logo glaxosmithkline
GSK is a global pharmaceutical company with a portfolio of innovative medicines and vaccines. Cutting edge immunology research, both in-house and through collaboration underpins the discovery of new medicines for many of our disease areas, such as autoimmunity, cancer, metabolic disease, infection and respiratory disease http://www.gsk.com/en-gb/research/. To take Industry-Academic collaboration in immunology to the next level, GSK is launching a new and unique model of sabbatical-based collaboration, designed to drive major breakthroughs in applied immunology and broaden scientific insight.

The Elion and Black Catalyst Sabbatical programme will select up to 5 leading academic immunologists focused on basic science to work alongside GSK industry scientists in a technology rich, multidisciplinary scientific environment: the “Immunology Catalyst”. Successful Immunology Catalyst candidates will continue to pursue their independent research programmes while at GSK and will have access to GSK’s technologies, tools and reagents. While on sabbatical, there is the added opportunity and advantage of leveraging the collective intelligence knowledge, expertise and creativity of multi-disciplinary GSK scientists, who regularly publish in leading peer-reviewed journals. The Immunology Catalyst programme also offers a unique insight into the science and leadership skills involved in drug discovery and translational research, and gives participants a chance to participate in scientific and strategic discussions about ongoing projects at GSK.

The Immunology Catalyst encourages academic freedom and innovation, original research, bold ideas and cross-disciplinary collaboration in emerging areas of immunology such as immunometabolism, innate immune cell memory, the influence of tissues on immune cell education and the interaction of the immune system with other systems, e.g. hormonal and neural elements.

The Immunology Catalyst will be supported and mentored by an advisory board of world class immunologists: Professors Vijay Kuchroo, Luke O’Neill, Jerry Nepom, Frank Nestle, Fiona Powrie, Maria-Grazia Roncarolo, Pam Sharma, Hergen Spits and Paul-Peter Tak.

This is a unique opportunity for academic scientists who wish to carry out a sabbatical in pursuit of their academic research projects with the added incentive of leveraging the formidable tools and technologies of industry. They can also participate in leadership and management training courses to support their personal development.

Sabbaticals at GSK are structured for up to 3 years. Flexible arrangements can also be made to suit individual candidates.

The Immunology Catalyst will be based at GSK’s world class R&D facility in Stevenage, UK. Stevenage is within easy reach of London (25 mins by train), Cambridge (45 mins by train) and Oxford (2 hrs by train), which form the UK’s biotech hub. GSK scientists have extensive collaboration networks in these locations and with other leading academic centres. Stevenage is situated near several small towns with good schools and infrastructure suitable for families.

Candidates:
Successful applicants should have a doctoral degree in immunology, or related field with an exceptional track record in leading independent research in immunology or a closely related discipline.

Research Support:
GSK would provide successful applicants with funding for cost of employment of the candidate (candidates will retain their employment contract with their home institution), a Research Associate and a Post-Doctoral fellow and an associated research budget. Laboratory space will be provided matching research needs. A grant would be provided to successful applicants for re-entry to academia for candidates who spend 3 years at GSK. The company may also offer assistance with relocation.

Application Procedure:
Please submit a cover letter containing the description of your major research achievements, a 2-3 page statement of research interests, a CV and the names and addresses of three individuals who can serve as references to This email address is being protected from spambots. You need JavaScript enabled to view it. by April 30th, 2015. Informal enquiries can be made to This email address is being protected from spambots. You need JavaScript enabled to view it.

Informal enquiries can also be made to the selection committee and advisory board: This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it. and This email address is being protected from spambots. You need JavaScript enabled to view it.

Member Society Spotlight: British Society for Immunology

rsz 2bsi photo
A plenary speaker talks during the 2014 British Society for Immunology meeting

The dynamism and energy which lies at the heart of the profession is something that I want to harness for our membership. The BSI is changing to meet the needs of immunologists and other stakeholders both in the UK and abroad: ours is a global effort and a global community. We are a broad church, representing those working in human and animal health, with patients with immune and allergic disorders but basing all that we do on cutting-edge laboratory research. Our organization leads and reflects our members and is diversifying as it moves into new terrains. Our portfolio of events, meetings and conferences reflects this change.The British Society for Immunology has a proud history, but an even more exciting future. It was founded in 1956 by a visionary group of like-minded scientists who foresaw the importance of the discipline at a time when few could have imagined how it would develop. We now have 6000 members spread across the world; we publish two journals, support our members in transforming the field and their careers, organize more than 60 scientific meetings every year and run a sensationally successful annual Congress that's both the social and scientific highlight of every autumn.

When the BSI was founded few could have foreseen the scale and importance of the breakthroughs we are now making in both basic and clinical research. Many early insights from fundamental immunological research are now being tested in the clinic, opening new worlds of therapy for a legion of hitherto untreatable diseases. Indeed, many of the new therapies now being licensed are not conventional 'small molecule' drugs but biotherapeutics based on immunological research. We are truly living in exciting times, but face challenges over research funding and changes in the university sector. We need a strong and unified voice in demonstrating the contributions that our discipline makes and in getting our voice heard by decision-makers and funders.

If you are not already a member, please do join us. Whatever the stage of your career or your specialist interest, you are welcome at the BSI. Further details can be found at www.immunology.org, but for now I’d like to leave you with is this thought: we can and will work with you, and you in turn can make a real contribution to a field that is transforming lives across the globe.

FOCIS Centers of Excellence: Milieu Intérieur Project – Institut Pasteur

email albert photo
Institut Pasteur FCE Director, Matthew Albert, MD, PhD

FOCIS Center of Excellence (FCE) Director Matthew Albert, MD, PhD, is coordinating a far-reaching project at the Institut Pasteur in Paris aimed at defining what it means to be "in good health" from a biological standpoint.

The project, known as "Milieu Intérieur" ("Environment Within"), strives to define and increase understanding of what determines a "healthy" individual from the perspective of their immune system by integrating for the first time the relationship between genetics, immunity, and environment.

Immune responses are extremely complex and vary form one person to another. However, medical practices and public health policies are mostly based on a single model of patient care and drug development. The Milieu Intérieur project, which is part of France's Laboratory of Excellence research consortium, was created specifically to address this paradox.

This project features a cohort of 500 French men and 500 French women between 20 and 69 years of age who are in good health. The project samples include blood, nasal and stool samples as well as skin biopsies. Scientists have also collected medical, nutritional and sociodemographic data, as well as information about individuals' lifestyles.

The statistical approach adopted by the scientists enabled them to validate known correlations between certain biological profiles and the age and sex of donors. It confirmed in particular that LDL cholesterol levels increase with age and that creatinine – which measures renal function – is higher in men than in woman.

FCE Web Site
The Milieu Intérieur Website

With the help of biological and epidemiological data, the scientists were also able to observe the impact of environmental factors, in particular smoking on the immune system. The study established that smoking may lead to an increase in white cells circulating in the blood stream, which causes the reduction of certain antibodies (IgG) and more.

In the long term, the Milieu Intérieur project aims to provide a new reference framework and data control system for patient studies. The study will help provide a better understanding of the variability of immune responses between individuals which can help with moving towards more personalized medicine.

The Milieu Intériur studies were published in the January issue of Clinical Immunology. The study includes thirty laboratories from top French research centers including the FCEs at Institut Curie and Paris-Diderot University.

The FOCIS Centers of Excellence (FCE) are an elite group of institutions who are the foundation of the interdisciplinary translational immunology community. This community offers an effective training environment for translational researchers and clinicians by promoting interdisciplinary innovation in research and clinical practices, and promoting new links for researchers and clinicians.

To learn more about the Milieu Intériur Project, visit http://www.milieuinterieur.fr/en.

Events/Related Meetings

American Rhinologic Society at COSM
April 23 – 24, 2015
Boston, Massachusetts, USA

74th Annual Meeting of the Society for Investigative Dermatology
May 6 – 9, 2015
Atlanta, Georgia, USA

28th Annual Canadian Society for Immunology Meeting
June 4 – 7, 2015
Winnipeg, Manitoba, Canada

Keystone Symposia: MicroRNAs & Noncoding RNAs in Cancer
June 7 – 12, 2015
Keystone, Colorado, USA

20th Nantes Infectious Diseases in Transplantation 2015 Meeting
June 11 – 12, 2015
Nantes, France

Basic Immunology in Medicine: Update 2015
Tuesday, June 23, 2015
Hilton San Diego Bayfront
San Diego, California, USA

Computational Immunology
Tuesday, June 23, 2015
Hilton San Diego Bayfront
San Diego, Calfornia, USA

Interventional Immunology
Wednesday, June 24, 2015
Hilton San Diego Bayfront
San Diego, California, USA

Clinical Trials in Immunologic Disease
Tuesday, June 24, 2015
Hilton San Diego Bayfront
San Diego, Calfornia, USA

FOCIS 2015
June 24 – 27, 2015
Hilton San Diego Bayfront
San Diego, California, USA

17th International Congress of Mucosal Immunology (ICMI 2015)
July 14 – 18, 2015
Berlin, Germany

2015 American Rhinologic Society Summer Sinus Symposium
July 17 – 18, 2015
Chicago, Illinois, USA

Association of Medical Laboratory Immunologists 28th Annual Meeting
August 14 – 17, 2015
New Orleans, LA, USA

41st Annual Meeting of the American Society for Histocompatibility and Immunogenetics
September 28 – October 2, 2015
Savannah, Georgia, USA

FOCIS 2016
June 22 – 25, 2016
Seaport Hotel & World Trade Center
Boston, Massachusetts, USA

Career Opportunities

From academia to government to industry; below are the openings available in the immunology job market! Click on each job posting to find out more details:

Postdoctoral Fellow Position
The MacKenzie Lab
University of California, San Francisco

Postdoctoral Research Position
Immunogenetics Center, Department of Pathology
University of California, Los Angeles

Scientist-Inflammation Biomarker – Translational Medicine
Amgen Inc.

Senior Scientist in Biotherapy
SME in Biotechnology

Staff Scientist and Research Fellow
Laboratory of Immunology, Clinical Immunology Section National Eye Institute (NEI)
National Institutes of Health (NIH) Department of Health and Human Services (DHHS)

Share